The Korean Journal of Medicine

  • 제79권3호
  • /
  • Pages.289-294
  • /
  • 2010
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

식도 협착과 다발성 내분비종 1형을 동반한 졸링거-엘리슨 증후군 1예

A case of Zollinger-Ellison syndrome with MEN-1

  • 공윤호 (울산대학교 의과대학 강릉아산병원 내과학교실) ;
  • 김영돈 (울산대학교 의과대학 강릉아산병원 내과학교실) ;
  • 한군희 (울산대학교 의과대학 강릉아산병원 내과학교실) ;
  • 이세형 (울산대학교 의과대학 강릉아산병원 내과학교실) ;
  • 정우진 (울산대학교 의과대학 강릉아산병원 내과학교실) ;
  • 장혁재 (울산대학교 의과대학 강릉아산병원 일반외과학교실) ;
  • 천갑진 (울산대학교 의과대학 강릉아산병원 내과학교실)
  • Kong, Yun-Ho (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Kim, Young-Don (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Han, Koon-Hee (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Lee, Se-Hyung (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Jung, Woo-Jin (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Jang, Hyuk-Jai (Department of General Surgery, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Cheon, Gab-Jin (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital)
  • 투고 : 2009.07.29
  • 심사 : 2009.09.25
  • 발행 : 2010.09.01
⟨ 이전 논문 다음 논문 ⟩

초록

56세 남자가 내원 2주 전부터 시작된 상복부 통증, 구토 그리고 설사를 주로로 내원하였으며 상부위장관 내시경 검사에서 역류성 식도염과 십이지장의 다발성 궤양을 보이고, 공복 혈청 가스트린 수치가 1,263 pg/mL 이상으로 정상의 10배 이상으로 상승되어 있어 Zollinger-Ellison 증후군으로 진단하였다. 복부 전산화단층촬영과 SRS를 통해 종양의 위치파악을 하고 수술적 절제를 하였으며, 부갑상선종이 동반되어 다발성내분비종 1형으로 진단하였다. 이후 PPI로 치료하였으나 식도 협착 소견이 반복되어 풍선확장술 및 식도 도관 삽입을 시행한 1예를 경험하여 보고한다.

Zollinger-Ellison syndrome (ZES) is a clinical syndrome caused by excessive gastric acid secretion by gastrinoma, characteristically causing peptic disease and/or gastroesophageal reflux disease. Approximately one third of patients with gastrinoma have multiple endocrine neoplasia type 1 (MEN-1). A 56-year-old man was admitted for abdominal pain and diarrhea lasting for 2 weeks. The endoscopic findings revealed severe reflux esophagitis and multiple ulcers at the bulb and second portion of the duodenum. He was diagnosed as ZES based on typical clinical features such as markedly elevated fasting gastrin level (${\geq}$1,263 pg/mL) and findings from a CT scan and somatostatin receptor scan. Pathologic findings after the operation revealed malignant gastrinoma. He was confirmed to have parathyroid adenoma and MEN-1. Despite antisecretory therapy with proton pump inhibitors, an esophageal stricture developed, and we performed esophageal balloon dilatation and stent insertion.

키워드

참고문헌

  1. Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 79:379-411, 2000 https://doi.org/10.1097/00005792-200011000-00004
  2. Jensen RT. Use of omeprazole and other proton pump inhibitors in the Zollinger-Ellison syndrome. In: Olbe L, ed. Milestones in drug therapy. 10th ed. p. 205, Basel, Birkhauser Verlag AG, 1999
  3. Mignon M, Cadiot G, Rigaud D, Ruszniewski PH, Jais P, Lehy T, Lewin MJ. Management of islet cell tumors in patients with multiple endocrine neoplasia type 1. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances in research and management. p. 342-359, Basel, Karger, 1995
  4. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142:709-723, 1955 https://doi.org/10.1097/00000658-195510000-00015
  5. Hoffmann KM, Gibril F, Entsuah LK, Serrano J, Jensen RT. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus. J Clin Endocrinol Metab 91:204-212, 2006 https://doi.org/10.1210/jc.2005-1349
  6. Gibril F, Schumann M, Pace A, Jensen RT. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 83:43-83, 2004 https://doi.org/10.1097/01.md.0000112297.72510.32
  7. Jensen RT. Gastrointestinal endocrine tumours: gastrinoma. Baillieres Clin Gastroenterol 10:603-643, 1996 https://doi.org/10.1016/S0950-3528(96)90016-0
  8. Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implication. Am J Surg 147:25-31, 1984 https://doi.org/10.1016/0002-9610(84)90029-1
  9. Ellison EH, Wilson SD. The Zollinger-Ellison syndrome: reappraisal and evaluation of 260 registered cases. Ann Surg 160:512-530, 1964 https://doi.org/10.1097/00000658-196409000-00013
  10. Creutzfeldt W, Arnold R, Creutzfeldt C, Track NS. Pathomorphologic, biochemical and diagnostic aspects of gastrinomas (zollinger-Ellison syndrome). Hum Pathol 6:47-76, 1975 https://doi.org/10.1016/S0046-8177(75)80109-2
  11. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635-644, 1999 https://doi.org/10.1056/NEJM199908263410902
  12. Orloff SL, Debas HT. Advances in management of patients with Zollinger-Ellison syndrome. Surg Clin North Am 75:511-524, 1995
  13. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 125:26-34, 1996
  14. van Eijck CH, Lamberts SW, Lemaire LC, Jeekel H, Bosman FT, Reubi JC, Bruining HA, Krenning EP. The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors. Ann Surg 224:119-124, 1996 https://doi.org/10.1097/00000658-199608000-00002
  15. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95:2271-2277, 2000 https://doi.org/10.1111/j.1572-0241.2000.02480.x
  16. Akerstrom G, Hessman O, Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch Surg 386:558-569, 2002 https://doi.org/10.1007/s00423-001-0274-6